OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results
03 août 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2023. Second quarter business...
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
25 juil. 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, July 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2023 after the close of the U.S....
OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results
03 mai 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, May 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2023. First quarter business...
OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
25 avr. 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, April 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2023 after the close of the U.S....
OPKO Health to Hold Virtual R&D Day on March 20, 2023
09 mars 2023 08h00 HE
|
OPKO Health, Inc.
MIAMI, March 09, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that it will hold an R&D Day event on March 20, 2023 beginning at 4:00 p.m. Eastern time. The two-hour...
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
08 mars 2023 08h00 HE
|
OPKO Health, Inc.
MDX-2201 leverages ModeX’s innovative biologics platform to target multiple Epstein-Barr virus (EBV) proteinsEBV is the leading cause of infectious mononucleosis and is also associated with some...
OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results
23 févr. 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, Feb. 23, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2022. Business highlights include...
OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
16 févr. 2023 11h41 HE
|
OPKO Health, Inc.
MIAMI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2022 after the close of the U.S....
OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 janv. 2023 08h00 HE
|
OPKO Health, Inc.
MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41st Annual J.P. Morgan Healthcare Conference being held January...
OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results
08 nov. 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, Nov. 08, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2022. Business highlights for the...